<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04936698</url>
  </required_header>
  <id_info>
    <org_study_id>202100365B0</org_study_id>
    <nct_id>NCT04936698</nct_id>
  </id_info>
  <brief_title>The Prevalence and Risk Factors for Thyroid Dysfunction in Pregnant Women in Taiwan</brief_title>
  <official_title>The Prevalence and Risk Factors for Thyroid Dysfunction in Pregnant Women in Taiwan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators' aim is to enroll around 2000 patients from Taipei, Keelung, Linkou, Chiayi&#xD;
      and Kaohsiung CGMH. All participants will receive universal thyroid function screening at 1st&#xD;
      trimester, and those who was found to have hyperthyroidism or hypothyroidism will be referred&#xD;
      to Endocrine department for further treatment. All participants will be followed at&#xD;
      outpatient clinic, and their obstetric visit finding will be recorded. The maternal and&#xD;
      neonatal outcomes will be analyzed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 16, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The prevalence thyroid dysfunction</measure>
    <time_frame>40 weeks</time_frame>
    <description>Hypothyroidism: defined as serum TSH &gt; 2.5U/mL and decreased fT4*; Hyperthyroidism: defined as fT4 &gt; normal range* and TSH undetectable&#xD;
* Serum free T4 range varies according to trimesters.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Thyroid Disease Pregnancy</condition>
  <arm_group>
    <arm_group_label>Hyperthyroidism</arm_group_label>
    <description>Elevated fT4, low TSH</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypothyroidism</arm_group_label>
    <description>Elevated TSH, low fT4</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Euthyroid</arm_group_label>
    <description>Normal TSH/fT4 level</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PTU 50 MG Oral Tablet</intervention_name>
    <description>to treat if the patient has hyperthyroidism</description>
    <arm_group_label>Hyperthyroidism</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levothyroxin</intervention_name>
    <description>to treat if the patient has hypothyroidism</description>
    <arm_group_label>Hypothyroidism</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women at their first trimester of pregnancy may be enrolled.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant women at first trimester (&lt; 14 weeks of gestational age)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tai-ho Hung, PhD</last_name>
    <phone>886-2-27135211</phone>
    <phone_ext>3179</phone_ext>
    <email>thh20@cgmh.org.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chen-ai Sung, MD</last_name>
    <phone>886-2-27135211</phone>
    <phone_ext>3410</phone_ext>
    <email>pgy1105@cgmh.org.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chang Gung Memorial hospital</name>
      <address>
        <city>Taipei City</city>
        <zip>105</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chen Ai Sung, M.D.</last_name>
      <phone>886-9-78835376</phone>
      <email>faithdafatty@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 17, 2021</study_first_submitted>
  <study_first_submitted_qc>June 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2021</study_first_posted>
  <last_update_submitted>August 12, 2021</last_update_submitted>
  <last_update_submitted_qc>August 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The decision will be made once the study is completed.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

